Zymeworks, Inc. (ZYME)

29.19 -0.71 (-2.37%) USD  |  NASDAQ  |  Sep 04, 16:00
29.20 +0.01 (+0.03%) After-Hours: 20:00
More

Zymeworks SG&A Expense (TTM) : 63.98M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ZYME.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 63.98M
March 31, 2026 59.60M
December 31, 2025 61.51M
September 30, 2025 62.27M
June 30, 2025 61.97M
March 31, 2025 62.70M
December 31, 2024 61.51M
September 30, 2024 60.14M
June 30, 2024 63.26M
March 31, 2024 69.29M
December 31, 2023 70.45M
September 30, 2023 85.75M
June 30, 2023 84.68M
March 31, 2023 78.21M
December 31, 2022 73.36M
September 30, 2022 49.08M
June 30, 2022 48.66M
March 31, 2022 53.36M
December 31, 2021 42.56M
September 30, 2021 50.67M
June 30, 2021 58.01M
March 31, 2021 51.56M
December 31, 2020 57.88M
September 30, 2020 74.16M
June 30, 2020 63.53M
Date Value
March 31, 2020 62.80M
December 31, 2019 64.18M
September 30, 2019 40.23M
June 30, 2019 35.51M
March 31, 2019 31.39M
December 31, 2018 29.46M
September 30, 2018 27.88M
June 30, 2018 25.72M
March 31, 2018 19.36M
December 31, 2017 18.55M
September 30, 2017 18.95M
June 30, 2017 16.36M
March 31, 2017 16.73M
December 31, 2016 12.55M
September 30, 2016 8.808M
June 30, 2016 7.306M
March 31, 2016 5.923M
December 31, 2015 5.217M
September 30, 2015 5.295M
June 30, 2015 4.95M
March 31, 2015 4.662M
December 31, 2014 3.945M
September 30, 2014 2.496M
June 30, 2014 1.647M
March 31, 2014 0.662M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Theravance Biopharma, Inc. 76.09M
BridgeBio Pharma, Inc. 645.86M
Aprea Therapeutics, Inc. 6.507M
ACADIA Pharmaceuticals, Inc. 620.29M
Alnylam Pharmaceuticals, Inc. 1.318B